<?xml version="1.0" encoding="UTF-8"?>
<codeBook version="2.5" ID="FRESH-PEF202-en" xml-lang="en" xmlns="ddi:codebook:2_5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:codebook:2_5 https://ddialliance.org/Specification/DDI-Codebook/2.5/XMLSchema/codebook.xsd">
<docDscr>
  <citation>
    <titlStmt>
      <titl>Somme Cancer Registry (Certified Registry 2013-2016)</titl>
      <IDNo>FRESH-PEF202-en</IDNo>
    </titlStmt>
    <prodStmt>
      <producer abbr="" affiliation="chu" role="">Olivier GANRY</producer>
    </prodStmt>
    <verStmt>
      <version></version>
    </verStmt>
  </citation>
</docDscr>
<stdyDscr>
  <citation>
    <titlStmt>
      <titl>
                Somme Cancer Registry (Certified Registry 2013-2016)            </titl>
      <IDNo agency="FReSH-lang">
                FRESH-PEF202-en            </IDNo>
      <IDNo agency="PEF">
                    202                </IDNo>
      <IDNo agency="FReSH">
                    FRESH-PEF202                </IDNo>
    </titlStmt>
    <rspStmt>
      <AuthEnty>
                    Olivier GANRY                                                                                                                            </AuthEnty>
      <AuthEnty affiliation="chu">
        <ExtLink title="ROR" URI="https://ror.org/010567a58" role="organisation id"/>
        <ExtLink title="SIREN" URI="268000148" role="organisation id"/>
      </AuthEnty>
      <AuthEnty>
                    Bénédicte LAPOTRE                                                                                                                            </AuthEnty>
      <AuthEnty affiliation="chu">
        <ExtLink title="ROR" URI="https://ror.org/010567a58" role="organisation id"/>
        <ExtLink title="SIREN" URI="268000148" role="organisation id"/>
      </AuthEnty>
      <othId affiliation="" type="">
                                    </othId>
    </rspStmt>
    <prodStmt>
      <producer role="sponsor">
                                            CENTRE HOSPITALIER UNIVERSITAIRE AMIENS-PICARDIE                    
                                    </producer>
      <prodPlac>
                Epidemiology France Portal (PEF)            </prodPlac>
    </prodStmt>
    <distStmt>
      <distrbtr abbr="null">
                    null</distrbtr>
      <contact affiliation="chu" email="ganry.olivier@chu-amiens.fr">
                    Olivier;GANRY
                                            <ExtLink title="ROR" URI="https://ror.org/010567a58" role="organisation id"/>
                                            <ExtLink title="SIREN" URI="268000148" role="organisation id"/>
                                    </contact>
      <contact affiliation="chu" email="lapotre-ledoux.benedicte@chu-amiens.fr">
                    Bénédicte;LAPOTRE
                                            <ExtLink title="ROR" URI="https://ror.org/010567a58" role="organisation id"/>
                                            <ExtLink title="SIREN" URI="268000148" role="organisation id"/>
                                    </contact>
      <depDate date="2026-06-16"/>
      <distDate date="2026-06-16"/>
    </distStmt>
    <biblCit format="">
            </biblCit>
    <holdings URI="null"/>
    <notes> </notes>
  </citation>
  <stdyInfo>
    <studyBudget/>
    <subject>
      <keyword vocab="" vocabURI="">
                    incidence</keyword>
      <keyword vocab="" vocabURI="">
                    survival</keyword>
      <topcClas vocab="health theme">
                        Oncology                                                        <ExtLink title="ESV" URI="http://data.europa.eu/8mn/euroscivoc/5784b7f1-c7ce-49d9-9f38-aebcda0ff41d"/>
                                                            <ExtLink title="MeSH" URI="http://id.nlm.nih.gov/mesh/D008495"/>
                                                </topcClas>
    </subject>
    <abstract contentType="purpose">Objectives of the registry in terms of public health (surveillance, evaluation): 1) Via an active and exhaustive listing of cases, a registry's main objective is to produce data enabling the calculation of indicators for monitoring the health of populations (incidence, survival and prevalence); 2) Such data is also made available to institutions - particularly decision-makers and local partners - to provide the département and Region with the necessary cancer-related expertise, by participating in various bodies (Regional Technical Committee for Oncology, Screening Committee, Regional Oncology Network ONCOPIC, etc.). The Registry takes part in cooperative research conducted via the FRANCIM and EUROCARE networks aimed at assessing medical practices within the population and disseminating recommendations; 3) The registry is also a tool for evaluating the efficacy of the screening campaigns organised in the département since 1990 for breast cancer and 2007 for colorectal cancer. It keeps track of incidence rate trends, the proportion of false negatives and interval cancers. Objectives of the registry in terms of research: 1) Evaluate the impact of public healthcare measurememts (organised screening programmes, regional health programmes, etc.); 2) Evaluate medical practices in the context of specific studies (high-resolution studies); 3) Develop research on the socioeconomic determining factors of survival and behaviour in cancer patients (e.g. the North-West canceropole VADS study underway, or planned breast cancer study in the Somme département) for a clearer understanding of the particularly marked disparities in healthcare access or use in the Somme département and to pinpoint the differences - from the city of Amiens' large IRIS zones (grouped areas for statistical information) - in incidence and types of cancer through work carried out jointly with the city of Amiens and the Regional Health Observatory (ORS); 4) Examine the issue of finding work again after cancer through the research theme of the canceropole care, reimbursement and survival of cancer patients; 5) Develop molecular epidemiology research within Young Team 2530 on breast cancer (Role of ion channels, hormones and growth factors in breast cancer); 6) Ongoing distance survey into the quality of life of people suffering from prostate cancer, diagnosed in 2001, QALIPRO.</abstract>
    <abstract contentType="abstract">null</abstract>
    <sumDscr>
      <collDate event="start" date="1982-01-01"/>
      <nation abbr="fr">
                    France
                                            <concept vocab="ISO" vocabURI="fr"/>
                                    </nation>
      <geogCover>Hauts-de-France</geogCover>
      <geogUnit/>
      <anlyUnit>
                Individuals            </anlyUnit>
      <universe level="type" clusion="I">Patients population                    </universe>
      <universe level="sex" clusion="I">Male                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D008297"/>
                                                    </universe>
      <universe level="sex" clusion="I">Female                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D005260"/>
                                                    </universe>
      <universe level="age" clusion="I">Infant, Newborn (birth to 28 days)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D007231"/>
                                                    </universe>
      <universe level="age" clusion="I">Infant (28 days to 2 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D007223"/>
                                                    </universe>
      <universe level="age" clusion="I">Child, Preschool (2 to 5 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D002675"/>
                                                    </universe>
      <universe level="age" clusion="I">Child (6 to 12 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D002648"/>
                                                    </universe>
      <universe level="age" clusion="I">Young Adult (19 to 24 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D055815"/>
                                                    </universe>
      <universe level="age" clusion="I">Adult (25 to 44 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D000328"/>
                                                    </universe>
      <universe level="age" clusion="I">Middle Aged (45 to 64 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D008875"/>
                                                    </universe>
      <universe level="age" clusion="I">Aged (65 to 79 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D000368"/>
                                                    </universe>
      <universe level="age" clusion="I">Aged, 80 and over (80 years and more)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D000369"/>
                                                    </universe>
      <universe clusion="I">All primitive in situ or malignant tumors in anyone living in the Somme département at the time of diagnosis, irrespective of where they are receiving treatment, are recorded. Moreover, non-invasive bladder tumours are systematically recorded, as well as benign tumours and tumours of intermediate malignancy of the central nervous system, and borderline tumours of the ovary. Basocellular skin carcinoma are excluded. Multiple tumours in the same subject are recorded, even if they occur simultaneously in paired organs or sub-locations of the same organ.                    </universe>
      <universe clusion="E">Basocellular skin carcinoma are excluded.                    </universe>
      <dataKind>Clinical data</dataKind>
      <dataKind>Biological data</dataKind>
      <dataKind>Socio-demographic data</dataKind>
    </sumDscr>
  </stdyInfo>
  <studyDevelopment>
    <developmentActivity type="primary evaluation">
      <description>Health event/morbidity</description>
    </developmentActivity>
  </studyDevelopment>
  <method>
    <dataColl>
      <sampProc>Other                                                            <concept vocab="CESSDA" vocabURI="Other"/>
                                                    </sampProc>
      <targetSampleSize>
        <sampleSizeFormula>&gt;= 20000 individuals                        </sampleSizeFormula>
      </targetSampleSize>
      <collMode>Interview with the participant (including clinical)                                                            <concept vocab="CESSDA" vocabURI="Interview"/>
                                                    </collMode>
    </dataColl>
    <notes>Observational Study</notes>
    <notes subject="research type">
                        Observational Study                    </notes>
    <notes subject="observational study method">
                        Morbidity registry                    </notes>
    <anlyInfo>
      <respRate>1982- 2008: 58,511 separate patients and 63,400 invasive tumours recorded by incidence (ENCR regulations and values on 01 January 2011).</respRate>
    </anlyInfo>
    <stdyClas>Unknown</stdyClas>
  </method>
  <dataAccs>
    <setAvail>
      <avlStatus>
                            Restricted access                                                    </avlStatus>
      <complete>The data communicated by the registry is anonymous.</complete>
    </setAvail>
    <useStmt>
      <conditions>Contact the person in charge of the registry, submit protocol or describe the project and its objectives.</conditions>
    </useStmt>
  </dataAccs>
  <othrStdyMat>
    <relMat>Access on specific project only</relMat>
  </othrStdyMat>
</stdyDscr>
<dataDscr>
</dataDscr></codeBook>
